Cibus (CBUS) Change in Receivables (2016 - 2025)
Cibus (CBUS) posted Change in Receivables of -$101000.0 for Q4 2025, up 71.06% sequentially from -$349000.0 in Q3 2025, and up 31.76% YoY from -$76656.4 in Q4 2024.
Cibus (CBUS) Change in Receivables (2016 - 2025) Analysis & Trends
Cibus has reported Change in Receivables for 8 years, with the latest figure at -$101000.0 in Q4 2025.
- Quarterly Change in Receivables rose 31.76% year-over-year to -$101000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$538000.0 (down 205.08% YoY) and the FY2025 annual result came in at -$538000.0, down 205.08% from the prior year.
- Change in Receivables advanced to -$101000.0 in Q4 2025 per CBUS's latest filing, from -$349000.0 in the prior quarter.
- Over five years, Change in Receivables peaked at $2.6 million in Q2 2021 and troughed at -$3.8 million in Q3 2021.
- A 4-year average of -$441133.3 and a median of -$101000.0 in 2025 frame the typical range for Change in Receivables.
- The sharpest annual moves came in 2021 and 2024: Change in Receivables sank 18138.1% in 2021, then surged 144.44% in 2024.
- Over 4 years, Change in Receivables stood at -$206000.0 in 2021, then surged by 85.44% to -$30000.0 in 2023, then plunged by 393.33% to -$148000.0 in 2024, then soared by 31.76% to -$101000.0 in 2025.
- According to Business Quant data, Change in Receivables over the past three periods registered -$101000.0, -$349000.0, and $3000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 140.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 838.50 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -53.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 117.58 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 31.60 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 94.29 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 37.16 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Cibus | 129.72 Mn | 109.29 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -101,000.00 |
| Dec 31, 2025 | -101,000.00 |
| Sep 30, 2025 | -349,000.00 |
| Sep 30, 2025 | -349,000.00 |
| Jun 30, 2025 | 3,000.00 |
| Jun 30, 2025 | 3,000.00 |
| Mar 31, 2025 | -91,000.00 |
| Mar 31, 2025 | -91,000.00 |
| Dec 31, 2024 | -148,000.00 |
| Dec 31, 2024 | -148,000.00 |
| Sep 30, 2024 | 132,000.00 |
| Sep 30, 2024 | 132,000.00 |
| Jun 30, 2024 | 408,000.00 |
| Jun 30, 2024 | 408,000.00 |
| Mar 31, 2024 | 120,000.00 |
| Mar 31, 2024 | 120,000.00 |
| Dec 31, 2023 | -30,000.00 |
| Dec 31, 2023 | -30,000.00 |
| Sep 30, 2023 | -297,000.00 |
| Sep 30, 2023 | -297,000.00 |